Longeveron Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Longeveron Inc
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty.
/ 
Frequently asked questions
To buy Longeveron Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Longeveron Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Longeveron Inc is LGVN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Longeveron Inc has its primary listing on NASDAQ. You can trade Longeveron Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Longeveron Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Longeveron Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Longeveron Inc.